Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Loss of angiopoietin-2 leads to region-specific brain malformations and blood-brain barrier leakage
Weihan Li, Elisa Vázquez-Liébanas, Chanaëlle Fébrissy, Florent Sauvé, Jianhao Wang, Doğan E. Sayıner, Pia Buslaps, Amanda Norrén, Michael Vanlandewijck, Liqun He, Marie Jeansson, Lars Muhl, Maarja Andaloussi Mäe
Weihan Li, Elisa Vázquez-Liébanas, Chanaëlle Fébrissy, Florent Sauvé, Jianhao Wang, Doğan E. Sayıner, Pia Buslaps, Amanda Norrén, Michael Vanlandewijck, Liqun He, Marie Jeansson, Lars Muhl, Maarja Andaloussi Mäe
View: Text | PDF
Research Article Cell biology Vascular biology

Loss of angiopoietin-2 leads to region-specific brain malformations and blood-brain barrier leakage

  • Text
  • PDF
Abstract

Angiopoietin-2 (ANGPT2) is known to destabilize vascular barriers in most peripheral organs; however, its role in the brain vasculature remains poorly understood. To investigate its physiological function within the brain vasculature, we analyzed constitutive Angpt2-knockout mice in adulthood. We showed that loss of ANGPT2 leads to region-specific vascular malformations and blood-brain barrier (BBB) dysfunction, resulting in differential permeability to 1 kDa and 70 kDa fluorescent tracers. Notably, overt vascular malformations appeared only in select brain regions that allowed leakage of both tracers. These malformations were characterized by dilated, intertwined, and sprouting endothelial cells, surrounded by reactive perivascular cells, along with high levels of astrocyte- and neuron-derived vascular endothelial growth factor A (VEGFA) and elevated expression of the vascular receptors VEGF receptor 2 (KDR) and neuropilin-1 (NRP1). Other cortical areas without obvious malformations exhibited significant leakage of the 1 kDa tracer. We also demonstrated that different cell types took up the tracers after passing the BBB. Our findings identified ANGPT2 as an important factor involved in the regulation of cerebrovascular architecture, barrier integrity, and endothelial-parenchymal interactions, and uncovered surprising differences in the leakage patterns and cellular uptake of two widely used BBB tracers.

Authors

Weihan Li, Elisa Vázquez-Liébanas, Chanaëlle Fébrissy, Florent Sauvé, Jianhao Wang, Doğan E. Sayıner, Pia Buslaps, Amanda Norrén, Michael Vanlandewijck, Liqun He, Marie Jeansson, Lars Muhl, Maarja Andaloussi Mäe

×

Figure 4

Glial phenotypes in Angpt2-KO brains.

Options: View larger image (or click on image) Download as PowerPoint
Glial phenotypes in Angpt2-KO brains.
(A) GFAP (yellow) and PECAM1 (red)...
(A) GFAP (yellow) and PECAM1 (red) IF tile scans of Angpt2-WT (n = 5) and -KO (n = 6) brains. High-magnification: malformed vasculature in CP with reactive GFAP+ astrocytes. Scale bars: 1 mm. (B) GFAP (yellow), AQP4 (cyan), and PECAM1 (red) IF in CP from WT (n = 3) and KO (n = 4). Scale bars: 25 μm. (C) GFAP (cyan), PECAM1 (yellow), TMR-dextran (red), and A488-cadaverine (green) IF in CP (n = 4). High-magnification single Z-plane: malformed vasculature and TMR-dextran deposits in between GFAP+ astrocytes and ECs. Scale bars: 50 μm. (D) AQP4 (cyan), PECAM1 (yellow), and TMR-dextran (red) IF in CP (n = 4). Scale: 50 μm. (E) GFAP+ area quantification in cortical regions and CP (n = 4). (F) AIF1+ cell count per field in cortical regions and CP of WT and KO (AI and ORB, n = 4; SS and CP, n = 5). Data normally distributed; 2-way ANOVA with Tukey’s test. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. (G and H) CLEC7A (yellow) (G), F4/80 (yellow) (H), AIF1 (cyan), and PECAM1 (red) IF in CP from WT (n = 3) and KO (n = 4). Scale bars: 25 μm. (I) LYVE1 (yellow), F4/80 (cyan), and PECAM1 (red) IF in CP from WT (n = 3) and KO (n = 4). Scale bars: 50 μm. (J) AIF1, F4/80 (cyan), PECAM1 (yellow), TMR-dextran (red), and A488-cadaverine (green) IF in CP (n = 4) showing TMR-dextran deposits colocalizing with F4/80+ and AIF1+ cells (arrowheads). Scale bars: 25 μm. (K) F4/80 (cyan), PECAM1 (yellow), TMR-dextran (red), and A488-cadaverine (green) IF in CP (n = 4). High-magnification single Z-plane: tangled vasculature with TMR-dextran deposits colocalizing with F4/80+ cells (arrowheads) or without (arrows). Scale bars: 25 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts